Femasys (FEMY) Current Leases (2020 - 2026)

Femasys (FEMY) reported Current Leases of $480286.0 for Q1 2026, down 5.86% on a YoY basis from $510171.0 in Q1 2025, and down 1.5% quarter-over-quarter from $487624.0 in Q4 2025.

Femasys (FEMY) Current Leases (2020 - 2026) Analysis & Trends

Femasys has reported Current Leases for 7 years, with the latest figure at $480286.0 in Q1 2026.

  • For the quarter ending Q1 2026, Current Leases fell 5.86% year-over-year to $480286.0; the trailing twelve-month figure through Mar 2026 stood at $480286.0 (down 5.86% YoY), and the FY2025 full-year result was $487624.0, down 5.86% from the prior year.
  • Current Leases for Q1 2026 stood at $480286.0, down from $487624.0 in the prior quarter.
  • The five-year high for Current Leases was $533734.0 in Q2 2024, with the low at $209098.0 in Q2 2023.
  • Historically, Current Leases has averaged $437297.5 across 5 years, with a median of $480286.0 in 2026.
  • Annual changes were most pronounced in 2023 — Current Leases plunged 47.0% — and 2024, when it surged 155.26%.
  • Femasys' Current Leases stood at $373833.0 in 2022, then advanced by 8.77% to $406636.0 in 2023, then climbed by 27.38% to $517967.0 in 2024, then declined by 5.86% to $487624.0 in 2025, then dropped by 1.5% to $480286.0 in 2026.
  • The last three Current Leases figures came in at $480286.0 (Q1 2026), $487624.0 (Q4 2025), and $494954.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Current Leases (Qtr)
1 Intuitive Surgical 148.09 Bn 143.69 Bn 1.83 Bn -
2 Becton Dickinson 41.00 Bn 39.99 Bn 2.15 Bn -
3 Medline 30.38 Bn 36.22 Bn 1.84 Bn -
4 Resmed 28.22 Bn 26.56 Bn 890.98 Mn 29.23 Mn
5 West Pharmaceutical Services 23.72 Bn 23.19 Bn 296.40 Mn 21.40 Mn
6 Solventum 13.33 Bn 13.33 Bn 1.10 Bn -
7 Cooper Companies 13.12 Bn 12.99 Bn 735.40 Mn -
8 Align Technology 12.86 Bn 11.80 Bn 736.59 Mn -
9 Baxter International 10.51 Bn 8.47 Bn 891.00 Mn -
10 Femasys 254.59 Mn 249.20 Mn - 480,286.00

Historic Data

Download Data
DateValue
Mar 31, 2026 480,286.00
Dec 31, 2025 487,624.00
Sep 30, 2025 494,954.00
Jun 30, 2025 502,468.00
Mar 31, 2025 510,171.00
Dec 31, 2024 517,967.00
Sep 30, 2024 525,752.00
Jun 30, 2024 533,734.00
Mar 31, 2024 494,967.00
Dec 31, 2023 406,636.00
Sep 30, 2023 410,219.00
Jun 30, 2023 209,098.00
Mar 31, 2023 305,071.00
Dec 31, 2022 373,833.00
Sep 30, 2022 386,139.00
Jun 30, 2022 394,518.00
Mar 31, 2022 400,620.00
Dec 31, 2021 406,674.00
Sep 30, 2021 412,911.00
Jun 30, 2021 419,333.00